Therakos LLC
Bridgewater, NJ Part of Medtronic Inc.
- UEI
- KGLHB9TM34M5
- CAGE
- 71TZ6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Medtronic Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Medtronic Inc. · Minneapolis, MN
D6JCTEWTMF46
-
Parent
Medtronic Inc. · Minneapolis, MN
D6JCTEWTMF46
- SAM.gov registration date
- Physical address
- 1170 US-22 #102, Bridgewater, NJ 08807, USA
- Website
- therakos.com
- Founded
- 1867
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $80,264 |
| FY2025 | $703,504 |
| FY2024 | $340,001 |
| FY2023 | $458,960 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $47,808 | |
| 2 | Department of Veterans Affairs | $32,456 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Phothera | Bryan, OH | 339113 Surgical Appliance and Supplies Manufacturing |
| Boston Scientific Corp | Marlborough, MA | 339112 Surgical and Medical Instrument Manufacturing |
| National Biological Corporation | — | 339112 Surgical and Medical Instrument Manufacturing |
| Brainlab Inc. | Westchester, IL | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Bayer Radiology | Hanover, NJ | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Therakos LLC, doing business as Therakos Inc., supplies extracorporeal photopheresis equipment, consumables, and pharmaceuticals to federal healthcare agencies as a prime contractor (100% of recent awards), competing on full-and-open contract vehicles with no set-aside designations. The company is a foreign-owned, for-profit subsidiary of Medtronic Inc., headquartered in Bridgewater, New Jersey, with operations in Hazelwood, Missouri and Nashville, Tennessee.
Therakos's federal footprint is entirely concentrated in two healthcare customer agencies. Veterans Integrated Service Network 9 (VA) dominates the portfolio, accounting for 50 awards and $10.7 million in combined potential value—roughly 80% of all work. The Department of Health and Human Services National Institutes of Health Clinical Center represents the second customer tier with 38 awards and $1.7 million combined potential value. Three other federal organizations (NIH Office of the Chief Operating Officer, Veterans Integrated Service Network 12, and the National Cancer Institute) account for 14 awards and $1 million combined potential value. The two largest customers' combined potential value represents 100% of the portfolio.
Therakos holds two core indefinite-delivery vehicles. A single-award Blanket Purchase Agreement with VA VISN 9, valued at $3.49 million and running through December 31, 2027, procures photopheresis light kits, UVADEX (methoxsalen) medication, and CELLEX procedural kits and supplies. Multiple BPA calls have been issued since the vehicle's September 2023 award; recent orders include $111,708 calls for CELLEX procedural kits (September 2025, June 2025), three $106,524 calls for photopheresis system kits (December 2024, October 2024, July 2024), and smaller calls ranging from $53,262 to $62,139. A single-award Indefinite Delivery Contract with VA VISN 9, valued at $163,904 and running through July 30, 2029, funds original equipment manufacturer preventive maintenance on CELLEX photopheresis units, with two delivery orders issued to date ($32,456 each). Therakos also maintains a $750,000 Federal Supply Schedule contract under Pharmaceuticals and Drugs (FSS-61-IB) and holds a $25,000 interim FSS agreement for hematology products.
Representative prime awards include a $48,750 purchase order from NIH Clinical Center in September 2026 for CELLEX USA kits; a $111,708 BPA call from VA VISN 9 in September 2025 for CELLEX procedural kits; a $46,545 purchase order from NIH Clinical Center in September 2025 for CELLEX kits; multiple $44,385 purchase orders from NIH Clinical Center for CELLEX photopheresis system procedural kits (issued across 2024 and 2025); and a $412,463 purchase order from VA VISN 9 awarded in October 2021 for photopheresis supplies to the Nashville VA Medical Center. Work centers on supplies for extracorporeal photopheresis procedures used to treat cutaneous T-cell lymphoma, graft-versus-host disease, and organ transplant rejection.
Award activity peaked in 2024 with 20 awards, declining to 7 awards in 2025 and 2 awards through September 2026. Across 102 total awards since 2014, Therakos has obligated $9 million (67% of combined potential value of $13.4 million). Recompete exposure in the next twenty-four months is minimal—only one award worth $49 thousand reaches ultimate completion inside that window. The vendor's NAICS profile reflects its product mix: Pharmaceutical Preparation Manufacturing (33 awards), In-Vitro Diagnostic Substance Manufacturing (12 awards), Analytical Laboratory Instrument Manufacturing (12 awards), and Surgical and Medical Instrument Manufacturing (11 awards). PSC codes cluster around Drugs and Biologicals (43 awards), Medical and Surgical Instruments (23 awards), and Laboratory Equipment and Supplies (20 awards). Therakos does not subcontract; all work is performed as a direct supplier to federal customer agencies.
Quick answers
Is Therakos LLC registered in SAM.gov?
Yes. Therakos LLC's SAM.gov registration is active through April 16, 2027.
Which contract vehicles does Therakos LLC hold?
Therakos LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Therakos LLC received in federal contracts?
Federal contracts obligated $703,504 to Therakos LLC in fiscal year 2025 and $1,582,730 in fiscal years 2023 through 2027.
How does Therakos LLC rank among federal contractors?
Therakos LLC's parent company, Medtronic Inc., ranked #13 in PSC 6515, #23 in PSC J065 and #26 in PSC 65 in FY2025.
What is Therakos LLC's most recent federal award?
Therakos LLC's most recent federal contract award is Cellex USA kits (75N98026P01818), from Office of Logisitics and Acquisition Operations (NIH), on September 24, 2026.
On GovTribe
See Therakos LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors